16-67675206-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_030819.4(GFOD2):c.1107G>T(p.Glu369Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_030819.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFOD2 | NM_030819.4 | c.1107G>T | p.Glu369Asp | missense_variant | 3/3 | ENST00000268797.12 | NP_110446.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFOD2 | ENST00000268797.12 | c.1107G>T | p.Glu369Asp | missense_variant | 3/3 | 1 | NM_030819.4 | ENSP00000268797.7 | ||
GFOD2 | ENST00000602377 | c.*785G>T | 3_prime_UTR_variant | 3/3 | 4 | ENSP00000477784.1 | ||||
GFOD2 | ENST00000602522.1 | n.2279G>T | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250940Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135654
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461584Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727132
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2024 | The c.1107G>T (p.E369D) alteration is located in exon 3 (coding exon 2) of the GFOD2 gene. This alteration results from a G to T substitution at nucleotide position 1107, causing the glutamic acid (E) at amino acid position 369 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at